Lesanpezeshki, Leila
Qadota, Hiroshi
Darabad, Masoud Norouzi
Kashyap, Karishma
Lacerda, Carla M. R.
Szewczyk, Nathaniel J.
Benian, Guy M.
Vanapalli, Siva A. https://orcid.org/0000-0001-6036-1949
Funding for this research was provided by:
National Institutes of Health (P40 OD010440)
Cancer Prevention and Research Institute of Texas (RP160806)
National Aeronautics and Space Administration (NNX15AL16G)
Biotechnology and Biological Sciences Research Council (BB/N015894/1)
National Institute of General Medical Sciences (R01 GM118534)
Article History
Received: 4 April 2021
Accepted: 8 July 2021
First Online: 13 August 2021
Declarations
:
: Not applicable.
: Not applicable.
: S. A. V. is the co-founder of NemaLife Inc. that commercializes <i>C</i>. <i>elegans</i> assays. The remaining authors declare that they have no competing interests.